|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Sylvain Martel (Polytechnique Montréal, Canada)Publisher: Pan Stanford Publishing Pte Ltd Imprint: Pan Stanford Publishing Pte Ltd Dimensions: Width: 15.20cm , Height: 1.30cm , Length: 22.90cm Weight: 0.430kg ISBN: 9789814745789ISBN 10: 9814745782 Pages: 160 Publication Date: 18 August 2016 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsIntroduction. The location. The interventional facility. The team at the planning briefing. The submarine. Miniaturization. Injection. Travelling in the artery. Tracking the position of the submarine. Propulsion and steering. Navigating in the bloodstream. The crew. Conclusion.ReviewsAuthor InformationSylvain Martel, fellow of the Canadian Academy of Engineering and of the IEEE, is chair of the IEEE Technical Committee on Micro-Nanorobotics and Automation and director of the NanoRobotics Laboratory at Polytechnique Montréal, Campus of the University of Montréal, Canada. He has received many awards, mostly in interdisciplinary research, and is a recipient of a Tier 1 Canada Research Chair in Medical Nanorobotics. He has developed several biomedical technologies, including platforms for remote surgeries and cardiac mapping systems, at McGill University and new types of brain implants for decoding neuronal activities in the motor cortex at MIT. Among other achievements, Prof. Martel’s research group is also credited for the first demonstration of the controlled navigation of an untethered object in the blood vessel of a living animal. At present, Prof. Martel is leading an interdisciplinary team involved in the development of navigable therapeutic agents and interventional platforms for cancer therapy. This research is based on a new paradigm in drug delivery pioneered by him and is known as direct targeting, where therapeutics are navigated in the vascular network toward solid tumors using the most direct physiological routes. This approach leading to a significant increase of the therapeutic index has been widely featured in The Globe and Mail, MIT Technology Review, New Scientist, The Economist, BBC, and Newsweek. Tab Content 6Author Website:Countries AvailableAll regions |